Liu Gan

Qingdao University

Papers

1

Total Citations

25

H-Index

1

About

Liu Gan is a clinical researcher whose work bridges surgical oncology and perioperative nutrition, with a particular focus on gastric cancer. His most-cited study, a 2021 randomized controlled trial examining the impact of drinking Chinese green tea on postoperative short-term outcomes for gastric cancer patients, has garnered 25 citations and represents a novel contribution to enhanced recovery after surgery (ERAS) protocols. By investigating caffeine-rich beverages as a means to stimulate bowel activity and reduce postoperative ileus—an approach previously explored with coffee—Gan’s work extends this concept to a culturally relevant intervention in Chinese green tea. This research not only addresses a practical clinical question but also integrates traditional dietary practices into evidence-based surgical care. Gan’s contributions are significant for their potential to improve patient recovery trajectories and reduce hospital stays, offering a low-cost, accessible intervention. His work is particularly valuable for researchers and clinicians interested in the intersection of nutrition, gastrointestinal surgery, and patient-centered outcomes, highlighting how everyday dietary choices can be leveraged for therapeutic benefit in oncology settings.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Impact of drinking Chinese green tea on postoperative short outcomes for gastric cancer: a randomized controlled trial
25 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Qingdao University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago